Emerging treatments for sarcoma: from 2024 onward.

Area of Science:

• Oncology
• Medical Genetics

Background:

• Sarcomas are rare mesenchymal tumors, comprising 1% of adult cancers, with limited systemic treatment options for advanced stages.
• Current treatments for localized sarcoma include surgery and radiotherapy, but overall survival for advanced disease remains poor (approx. 20 months).

Purpose of the Study:

• To review recent advancements in sarcoma clinical trials and novel therapeutic approaches.
• To examine insights from genomic profiling for developing next-generation sarcoma therapies.

Main Methods:

• Literature review of recent clinical trials in sarcoma.
• Analysis of findings from comprehensive genomic profiling studies in sarcoma.

Main Results:

• Recent progress includes novel chemotherapeutics, targeted therapies, and immunotherapeutics for sarcomas.
• Despite advancements, modest survival improvements and concerns about cost-benefit and adverse effects persist.

Conclusions:

• There is an urgent need for refined clinical trial designs and novel therapies to improve outcomes for sarcoma patients.
• Genomic insights offer a pathway for developing more effective, next-generation therapeutic strategies for diverse sarcoma subtypes.